GILEAD SCIENCES, INC. (GILD) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
42/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseGILD / S&P -8.75% / 15.20% |
LoseGILD / S&P 5.52% / 15.00% |
LoseGILD / S&P -153.19% / 50.40% |
| 2026-Q12/3 |
WinGILD / S&P 14.19% / -4.33% |
LoseGILD / S&P 3.48% / 11.30% |
WinGILD / S&P 54.53% / 27.70% |
| 2025-Q42/3 |
WinGILD / S&P 11.31% / 2.65% |
LoseGILD / S&P 2.40% / 9.00% |
WinGILD / S&P 1729.73% / 13.40% |
| 2025-Q31/3 |
LoseGILD / S&P 0.81% / 8.12% |
LoseGILD / S&P 2.78% / 4.61% |
WinGILD / S&P 7962.50% / 13.45% |
| 2025-Q21/3 |
LoseGILD / S&P -0.35% / 10.94% |
LoseGILD / S&P 3.81% / 4.83% |
WinGILD / S&P 519.75% / 10.63% |
| 2025-Q12/3 |
WinGILD / S&P 22.16% / -4.27% |
LoseGILD / S&P 4.68% / 4.98% |
WinGILD / S&P 1257.14% / 10.57% |
| 2024-Q42/3 |
WinGILD / S&P 11.10% / 2.41% |
WinGILD / S&P 6.04% / 5.25% |
LoseGILD / S&P -91.76% / 6.15% |
| 2024-Q31/3 |
WinGILD / S&P 23.34% / 5.89% |
LoseGILD / S&P 3.31% / 5.89% |
LoseGILD / S&P -98.28% / 6.11% |
| 2024-Q20/3 |
LoseGILD / S&P -5.19% / 4.28% |
LoseGILD / S&P 1.54% / 5.38% |
LoseGILD / S&P -81.38% / 5.12% |
| 2024-Q10/3 |
LoseGILD / S&P -8.65% / 10.56% |
LoseGILD / S&P 1.51% / 5.71% |
LoseGILD / S&P -92.10% / 5.59% |
| 2023-Q41/3 |
LoseGILD / S&P 9.08% / 11.69% |
LoseGILD / S&P -0.60% / 6.81% |
WinGILD / S&P 23.01% / 7.78% |
| 2023-Q32/3 |
WinGILD / S&P -1.81% / -3.27% |
LoseGILD / S&P 0.94% / 7.52% |
WinGILD / S&P 75.85% / -5.03% |
| 2023-Q21/3 |
LoseGILD / S&P -6.21% / 8.74% |
LoseGILD / S&P -0.48% / 9.50% |
WinGILD / S&P 32.62% / -8.57% |
| 2023-Q11/3 |
LoseGILD / S&P -2.43% / 7.50% |
LoseGILD / S&P -1.56% / 10.77% |
WinGILD / S&P 23.74% / -15.69% |
| 2022-Q41/3 |
WinGILD / S&P 40.32% / 7.56% |
LoseGILD / S&P -0.09% / 11.88% |
LoseGILD / S&P -25.96% / -17.99% |
| 2022-Q31/3 |
WinGILD / S&P 0.94% / -4.88% |
LoseGILD / S&P -1.26% / 13.47% |
LoseGILD / S&P -54.86% / -1.41% |
| 2022-Q21/3 |
WinGILD / S&P 5.27% / -16.10% |
LoseGILD / S&P 3.29% / 13.71% |
LoseGILD / S&P -20.19% / 11.04% |
| 2022-Q11/3 |
LoseGILD / S&P -17.08% / -4.60% |
LoseGILD / S&P 7.46% / 15.97% |
WinGILD / S&P 1391.67% / 42.23% |
| 2021-Q41/3 |
LoseGILD / S&P 5.01% / 11.03% |
LoseGILD / S&P 10.60% / 15.00% |
WinGILD / S&P 5377.78% / 96.40% |
| 2021-Q33/3 |
WinGILD / S&P 2.46% / 0.58% |
WinGILD / S&P 18.73% / 10.77% |
WinGILD / S&P 505.15% / 69.42% |
| 2021-Q21/3 |
LoseGILD / S&P 7.66% / 8.55% |
WinGILD / S&P 20.13% / 6.58% |
LoseGILD / S&P -1812.50% / 51.81% |
| 2021-Q12/3 |
WinGILD / S&P 12.20% / 6.17% |
WinGILD / S&P 12.54% / -1.06% |
LoseGILD / S&P -93.83% / 7.39% |
| 2020-Q41/3 |
LoseGILD / S&P -6.76% / 12.15% |
WinGILD / S&P 9.98% / -3.72% |
LoseGILD / S&P -97.86% / -33.42% |
| 2020-Q31/3 |
LoseGILD / S&P -17.01% / 8.93% |
WinGILD / S&P 3.50% / -2.04% |
LoseGILD / S&P -54.03% / -27.10% |
| 2020-Q20/3 |
LoseGILD / S&P 3.83% / 20.54% |
LoseGILD / S&P -0.82% / -0.46% |
LoseGILD / S&P -105.18% / -27.11% |
| 2020-Q12/3 |
WinGILD / S&P 16.12% / -19.60% |
LoseGILD / S&P 1.77% / 3.47% |
WinGILD / S&P -14.51% / -14.75% |
| 2019-Q40/3 |
LoseGILD / S&P 3.49% / 9.07% |
LoseGILD / S&P 1.46% / 5.36% |
LoseGILD / S&P 0.72% / 2.99% |
| 2019-Q31/3 |
LoseGILD / S&P -5.31% / 1.70% |
LoseGILD / S&P 0.38% / 5.02% |
WinGILD / S&P 71.54% / 0.21% |
| 2019-Q22/3 |
WinGILD / S&P 4.91% / 4.30% |
LoseGILD / S&P -3.62% / 6.64% |
WinGILD / S&P 173.96% / 8.65% |
| 2019-Q11/3 |
LoseGILD / S&P 4.94% / 13.65% |
LoseGILD / S&P -9.60% / 8.12% |
WinGILD / S&P 73.00% / 14.29% |
| 2018-Q41/3 |
LoseGILD / S&P -18.30% / -13.52% |
LoseGILD / S&P -15.24% / 9.05% |
WinGILD / S&P 19.09% / 18.23% |
| 2018-Q31/3 |
WinGILD / S&P 9.84% / 7.71% |
LoseGILD / S&P -18.91% / 10.21% |
LoseGILD / S&P -86.01% / 19.06% |
| 2018-Q20/3 |
LoseGILD / S&P -5.28% / 3.43% |
LoseGILD / S&P -18.51% / 9.03% |
LoseGILD / S&P -81.67% / 14.46% |
| 2018-Q11/3 |
WinGILD / S&P 5.98% / -0.76% |
LoseGILD / S&P -15.16% / 7.68% |
LoseGILD / S&P -72.23% / 12.46% |
| 2017-Q40/3 |
LoseGILD / S&P -10.97% / 6.64% |
LoseGILD / S&P -14.09% / 7.03% |
LoseGILD / S&P -64.72% / 13.82% |
| 2017-Q31/3 |
WinGILD / S&P 15.18% / 4.48% |
LoseGILD / S&P -12.98% / 5.68% |
LoseGILD / S&P -18.46% / 17.57% |
| 2017-Q21/3 |
WinGILD / S&P 5.05% / 3.09% |
LoseGILD / S&P -12.06% / 4.83% |
LoseGILD / S&P -18.77% / 17.74% |
| 2017-Q10/3 |
LoseGILD / S&P -4.42% / 6.07% |
LoseGILD / S&P -11.38% / 3.67% |
LoseGILD / S&P -18.99% / 13.32% |
| 2016-Q40/3 |
LoseGILD / S&P -8.91% / 3.82% |
LoseGILD / S&P -6.89% / 2.09% |
LoseGILD / S&P -16.53% / 7.05% |
| 2016-Q32/3 |
LoseGILD / S&P -4.58% / 3.85% |
WinGILD / S&P 0.41% / 0.20% |
WinGILD / S&P -1.19% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | GILD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 35.20% | 20.78% |
| Annualized return | 35.20% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | GILD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 148.59% | 83.14% |
| Annualized return | 19.98% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | GILD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 173.98% | 319.30% |
| Annualized return | 10.60% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |